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Introduction
The mechanisms involved in maintaining the mammalian
epidermal stem cell population remain largely uncharacterised
due in part to the lack of epidermal stem cell specific markers.
Epidermal stem cells remain relatively quiescent in vivo, but
are capable of generating new epidermal tissue via their
daughter cells, otherwise known as transit amplifying (TA)
cells, which have a low self-renewing capacity but cycle
rapidly (Janes et al., 2002). Epidermal stem cell populations of
mammalian skin reside in at least two locations: a specialised
region of the hair follicle (HF) known as the hair bulge, and in
a non-random distribution within the basal cells of the
interfollicular epithelium (the keratinocyte stem cell (KSC)
population). The KSC and TA cell populations comprise 70-
80% of the basal cell population, express high levels of keratin
5 (K5) and keratin 14 (K14), b 1 integrin and a 6b 4 integrin
(Jones and Watt, 1993; Li et al., 1998), and represent
the interfollicular epidermal progenitor compartment. The
remaining 20-30% of basal cells comprise postmitotic-
differentiating (PMD) cells, which have ceased cell cycle
activity and begun the process of terminal differentiation, and
non-epithelial cells such as leucocytes, and melanocytes. A
well-accepted definition of quiescent stem cells in vivo is the
ability to retain 3H-Tdr label for 8 weeks or more (Albert et
al., 2001; Bickenbach and Chism, 1998; Tani et al., 2000).
These label-retaining cells (LRCs) can be distinguished from
b 1 integrinbright TA cells by their characteristic low levels of
CD71 transferrin receptor expression in adult (but not
embryonic) skin (Li et al., 1998; Tani et al., 2000). Melanoma
chondroitin sulphate proteoglycan (MCSP) is also expressed in
the human HF stem cell compartment, although its expression
does not enrich a b 1 integrinbright population for stem cells,
indicating it is not a useful marker for interfollicular or murine
epidermal stem cell populations (Legg et al., 2003). Although
it has been suggested that the p53 homologue, p63, acts as a
potential marker of epidermal KSCs (Pellegrini et al., 2001),
its widespread expression throughout the basal layer is not
consistent with the low incidence of LRCs. However, recent
evidence suggests that p63 expression is required to maintain
basal cell proliferative activity (Koster and Roop, 2004;
McKeon, 2004), and is therefore useful as a marker of KSC
Despite the well-characterised role of sonic hedgehog (Shh)
in promoting interfollicular basal cell proliferation and
hair follicle downgrowth, the role of hedgehog signalling
during epidermal stem cell fate remains largely
uncharacterised. In order to determine whether the three
vertebrate hedgehog molecules play a role in regulating
epidermal renewal we overexpressed sonic (Shh), desert
(Dhh) and Indian (Ihh) hedgehog in the basal cells of mouse
skin under the control of the human keratin 14 promoter.
We observed no overt epidermal morphogenesis phenotype
in response to Ihh overexpression, however Dhh
overexpression resulted in a range of embryonic and
adult skin manifestations indistinguishable from Shh
overexpression. Two distinct novel phenotypes were
observed amongst Shh and Dhh transgenics, one exhibiting
epidermal progenitor cell hyperplasia with the other
displaying a complete loss of epidermal tissue renewal
indicating deregulation of stem cell activity. These data
suggest that correct temporal regulation of hedgehog
activity is a key factor in ensuring epidermal stem cell
maintenance. In addition, we observed Shh and Dhh
transgenic skin from both phenotypes developed lesions
reminiscent of human basal cell carcinoma (BCC),
indicating that BCCs can be generated despite the loss of
much of the proliferative (basal) compartment. These data
suggest the intriguing possibility that BCC can arise
outside the stem cell population. Thus the elucidation
of Shh (and Dhh) target gene activation in the skin will
likely identify those genes responsible for increasing the
proliferative potential of epidermal basal cells and the
mechanisms involved in regulating epidermal stem cell fate.
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and TA cell populations. Although Shh has not yet been shown
to directly influence the stem cell population of the skin, it is
well characterised that mammalian Shh, normally expressed in
the basal cells of the skin, promotes epidermal proliferation.
Shh is required to induce the proliferation and downgrowth of
follicular epithelium (Chiang et al., 1999; Karlsson et al., 1999;
St-Jacques et al., 1998), as observed by a failure of HFs to grow
down into the dermis of Shh null mice (St-Jacques et al., 1998).
Overexpression of Shh in the skin results in epidermal
hyperplasia by antagonising p21 cell cycle arrest (Fan and
Khavari, 1999) and results in the proliferation of HF-like
structures into basal cell carcinoma (BCC)-like growths (Fan
et al., 1997; Oro et al., 1997). Recent evidence also suggests
that Indian hedgehog (Ihh), another mammalian hedgehog
homologue, has epidermal tumorigenic potential. Mice
overexpressing D N-Lef1 in the basal cells of mouse skin,
which blocks b -catenin signalling, develop sebaceous tumours
that express Ihh (Niemann et al., 2003), leading to the
hypothesis that Ihh may play a role in stimulating the
proliferation of undifferentiated sebocytes. Thus it appears that
both Shh and Ihh signalling pathways may play a role in the
proliferation of different epidermal stem cell fate lineages.
In order to determine the tumorigenic potential of Shh, Dhh
and Ihh, and to establish whether they play a role in regulating
the epidermal stem cell population of the interfollicular, hair
follicle or sebaceous lineages, we overexpressed each of the
hedgehog genes in the basal layer of the skin via the keratin
14 promoter. A subset of Shh and Dhh transgenic embryos
presented with a marked expansion of epidermal progenitor
cells, an increase in basal cell proliferative activity and a delay
in basal cell differentiation. In addition, we observed several
Shh and Dhh transgenic embryos that lacked epidermal
proliferative activity and cell/tissue renewal potential. Our
results show for the first time that hedgehog signalling in the
proliferative compartment of the epidermis plays an important
role in regulating homeostatic cell renewal of the skin, and
indicate that manipulation of the hedgehog pathway may
provide a useful tool for the experimental investigation of
epidermal tissue regeneration and for the ex-vivo expansion of
epidermal progenitors for clinical applications.
Materials and methods
Production of transgenic mice
BglII linkered primers were used to PCR amplify the complete open
reading frame of mouse Shh (Shh5¢ : GAA GAT CTT CAC CAT GCT
GCT GCT GCT GGC CAG, Shh3¢ : GAA GAT CTT CTC AGC TGG
ACT TGA CCG CCA), mouse Dhh (Dhh5¢ : CAG AGA TCT CCC
ACC ATG CCC GAG CGG ACC, Dhh3 ¢ : CTA GAT CTT CAG CCC
ATT AAC TCC TCG), and mouse Ihh (Ihh5 ¢: CCA AGA TCT CCC
AGC ATG GAG TCC CCA AGA G, Ihh3 ¢ : CGC AGA TCT GTT
CCA GGT GGG CAG), and cloned into the BamHI linearised human
keratin 14 (K14) promoter and confirmed by direct sequencing. The
hedgehog-transgene (hK14-Hh) inserts were released from the
plasmid backbone by EcoRI/HindIII double digests and pronuclear
injection of the DNA performed on E0.5 BCBF1 3 Quackenbush
embryos. Injected embryos were transferred into the uteri of pseudo
pregnant female CD1 recipients. All transgenic progeny were
identified via PCR analysis of tail tip DNA using human K14 specific
primers: (K14AF: 5¢ -TCT CGC CTC TCT CTG GTC AT-3 ¢ and
K143¢ R: 5¢ -CCT GAT CAC AAA AAC ATC AGG A-3 ¢ ). These
primers generated a 328 bp fragment when cycled under the following
conditions: 94°C 2 minutes, then 94°C 45 seconds, 50°C 45 seconds,
72°C 45 seconds for 30 cycles.
Histology and immunohistochemistry
Back skin from E17.5 or E18.5 embryos were fixed overnight in 4%
paraformaldehyde in PBS, and embedded in paraffin. Histological
analysis was performed on 4 m m sections stained with haematoxylin
and eosin. Antibody markers were analysed on 4 m m tissue sections
via standard immunofluorescence and immunohistochemistry
techniques using the following antibodies: K14 (1/10,000), K6
(1/500), K10 (1/500) loricrin (1/500) (Babco), Ki67 (1/500) (Novo
Castra), PCNA (1/100) (ZYMED laboratories), p63 (1/100) (gift from
Dr F. McKeon), Ihh (1/30) (C-15; Santa Cruz).
In situ hybridisation
RNA in situ analyses were performed on 14 m m paraffin-embedded
skin sections using Digoxigenin (DIG)-labelled RNA probes. Sections
were rinsed in xylene then hydrated through a graded ethanol series.
Sections were treated with 10 m g/ml proteinase K for 10 minutes at
37° C, rinsed in PBS, fixed in 4% PFA for 10 minutes, rinsed in PBS,
acetylated in 0.1 M triethanolamine/0.25% acetic anhydride for 10
minutes. Sections were then dehydrated through a graded ethanol
series and xylene, then allowed to air dry. Then 500 m g of RNA probe
plus 1 mg/ml of salmon sperm were heated at 80 ° C for 5 minutes, and
added to 500 m l of hybridisation solution solution (50% formamide,
10% dextran sulphate, 10 mM Tris-HCl, 10 mM EDTA, 0.6 M NaCl,
10 mM dithiothreitol (DTT), 13Denhardt’s solution, 0.25% sodium
dodecyl-sulphate (SDS) and 200 m g/ml yeast total RNA). RNA probes
were hybridised overnight at 64 ° C in a humidified chamber. Washing
and blocking steps were performed using DIG wash and block buffer
set (Roche) as per manufacturer’s instructions. Colour detection was
performed using Nitro-blue tetrazolium (NBT) and 5-bromo-4-
chloro-3-indolylphosphate (BCIP) in the presence of 50 mM MgCl2
and 10% polyvinyl alcohol. Samples were then fixed in 8%
formamide for 60 minutes, dehydrated through a graded ethanol series
and xylene, and mounted in xylene-based mounting media. Transgene
RNA expression was detected using a 328 bp antisense RNA probe,
made from PCR amplification of the K14 poly A region of the
promoter (see primer sequences above). Ptc2, Gli1, Gli2, Gli3 and
Shh RNA probes were kindly provided by Dr C. C. Hui. The Ptc1
probe has been previously described (Hahn et al., 1996).
Skin grafts
Skin samples for grafting were prepared and grafted onto 6- to 10-
week-old female, SCID recipient mice as previously described
(Mayumi et al., 1988). Recipient mice were shaved, and the graft
dressed and bandaged. Dressings were removed seven days post-graft
and skin phenotype noted weekly.
Keratinocyte cell culture
Primary keratinocytes were isolated from the skin of E18.5 embryos
as described by Hager et al. (Hager et al., 1999). Proliferative basal
cells were selected via rapid attachment (10 minutes) onto
vitrogen/fibronectin-coated 60 mm dishes and cultured in keratinocyte
growth media (EMEM, 8% chelex-treated fetal bovine serum, 4 ng/ml
epidermal growth factor (EGF) and 50% fibroblast conditioned
media), with media changes every second day. After 4 weeks of
incubation, cells were fixed in 100% ethanol at –20 ° C for 20 minutes,
and stained with 1% crystal violet.
Results
Ectopic expression of Shh results in perinatal
lethality and a range of developmental phenotypes
Shh was expressed in mouse epithelial cells from E9.5 under
the control of the hK14 promoter. Due to perinatal lethality
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associated with the embryonic phenotypes, transgenic
embryos were produced via independent pronuclear
injections and thus establishment of transgenic lines was not
possible. We analysed 27 independent Shh transgenic
embryos at E17.5 or E18.5 and although embryonic
phenotypes varied significantly in their severity, transgenic
embryos could be categorised into four groups according to
skin phenotype (Table 1). The first group of hK14-Shh
transgenics (10/27) exhibited no overt epidermal anomalies
and were indistinguishable from wild-type embryos with
respect to skin phenotype (herein referred to as ShhRegular)
(Fig. 1A). The only anomaly observed in ShhRegular embryos
was the presence of a postaxial (posterior) nubbin of digit V
(Fig. 1A), often in association with duplication of digit I (Fig.
1B,G) or II. The second group of hK14-Shh transgenics
(8/27) displayed a wrinkled skin phenotype (herein referred
to as ShhWrinkled). ShhWrinkled embryos were larger than wild-
type littermates, developed pre-axial polysyndactyly (Fig.
1C,H) and severe soft-tissue syndactyly. Although the skin of
ShhWrinkled embryos maintained the opacity of wild-type skin
it was substantially wrinkled, exhibiting excessive skin folds
(Fig. 1K and Fig. 3B). In addition, blistering of the skin was
evident over varying degrees of spina bifida and exposed fore-
, mid- and hindbrain regions (Fig. 1L). A number of hK14-
Shh transgenics (2/27), referred to as ShhTaut, displayed pre-
axial polysyndactyly and taut (lacking in skin folds) opaque
skin with irregularly spaced blisters (Fig. 3C: black arrows).
The phenotype of ShhTaut embryos paralleled that described
in the previously published report of K14-Shh transgenic
mice (Oro et al., 1997). The remaining hK14-Shh transgenics
(7/27) were referred to as ShhTranslucent and exhibited the most
severe developmental dysmorphologies (Fig. 1J,K). The
limbs from 4/7 ShhTranslucent embryos displayed
polysyndactyly (Fig. 1L,M), with a marked shortening of the
proximal-distal axis. The remaining 3/7 ShhTranslucent
embryos presented with paddle-shaped limb buds that
appeared developmentally similar to E11.5-12.5 wild-type
limbs (Fig. 1N) and no obvious cartilage or digit formation
(Fig. 1O). Craniofacial structures of the ShhTranslucent
embryos displayed severe developmental defects including
cleft palate, fronto-nasal bossing, clefting of the lower jaw
(Fig. 1J) and complete lack of cranial and vertebral closure
(Fig. 1K). The skin of ShhTranslucent embryos was entirely taut,
shiny and translucent, with minimal epidermal thickening or
keratinisation, reminiscent of early embryonic epidermis
(E14.5-15.5). The ShhTranslucent epidermal phenotype closely
resembles that of the p63 null mouse, which has been
suggested to model the loss of epidermal stem cell renewal
(Yang et al., 1999). Further description of hK14-Shh
transgenics will be restricted to the two novel and
uncharacterised skin phenotypes, ShhWrinkled and
ShhTranslucent.
Fig. 1. Range of developmental
phenotypes resulting from ectopic
hedgehog signalling activity. Shh, Dhh and
Ihh overexpression gave rise to Regular
transgenic embryos that present with skin
indistinguishable from wild-type epidermis
(A), and mild limb phenotypes such as a
post-axial nubbin (B, arrowhead) and/or
digit duplication (C, arrowhead; D, alcian
blue staining of digit duplication). A
subset of Shh and Dhh transgenics
presented with a Wrinkled skin phenotype
which presented with grossly wrinkled
skin (E,F) and blisters over regions of
exposed brain (G, arrow) and spinal cord
(G, star), pre-axial polydactyly (H-K),
complete inter-digital soft tissue webbing
(H, arrows), excessive soft-tissue (J, arrow)
and calcification at the distal tip (K,
arrowhead). Shh and Dhh overexpression
also gave rise to Translucent embryos
[displayed severe developmental defects
(L,M)] and Translucent limbs often lacked
proximal distal growth, presenting as limb
buds (N,O, arrowheads).
Table 1. Number of skin phenotypes produced from each
hedgehog-transgenic construct
Phenotype
Regular Wrinkled Taut Translucent
hK14-Shh 10 (7)* 8 (3)* 2 (4)* 7 (4)*
hK14-Dhh 11 4 4 4
hK14-Ihh 28 0 0 0
*Numbers in brackets represent the number of skin phenotypes produced
by Shh overexpression that were unavailable for further analysis due to
sample degradation.
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Shh pathway activity promotes basal cell
hyperplasia and BCC formation
Keratin 14 is a marker of epidermal basal cells and is
normally expressed in a single layer of interfollicular basal
cells and the outer root sheath (ORS) cells of the hair follicle
in wild-type epidermis (Fig. 2A,D). In ShhWrinkled transgenic
epidermis we observed disorganised K14 mRNA (Fig. 2B)
and protein (Fig. 2E) expression in up to 12 cell layers.
Hyperplasia (Fig. 3E) was restricted to the basal cell
compartment as confirmed by the appropriate number of
stratified layers (loricrin, Fig. 2K and keratin 10, data not
shown). The basal cells of ShhWrinkled epidermis were found
to express high levels of keratin 6 (K6, a hyperproliferative
marker, Fig. 2H), Ki67 (a mitotic activity marker, data not
shown) and the proliferating cell nuclear antigen (PCNA)
marker (Fig. 2N), indicating an increased number of basal
cells undergoing proliferative activity. In wild-type skin,
epidermal stratification begins, and hence the terminal
differentiation markers K10 and loricrin are expressed, as
soon as the basal cells detach from the basement membrane
(Fig. 2J). In ShhWrinkled skin we note the late onset of terminal
differentiation markers in up to ten layers from the basement
membrane (loricrin, Fig. 2K and keratin 10, data not shown).
These results suggest that Shh promotes epidermal
hyperplasia by inhibiting the onset of epidermal stratification,
thereby acting to maintain epidermal basal cells in a
proliferative state. The embryonic epidermis of ShhWrinkled
transgenics also displayed a variety of skin lesions some of
which resembled human BCCs (Fig. 3G-I). The embryonic
BCC-like lesions observed in ShhWrinkled mice displayed
characteristics of human BCCs including palisading cells at
the tumour border and retraction sites where the tumour
epithelium is separated from the mesenchyme (clefting) (Fig.
3G,I, arrows), and antibody profiles paralleled that of human
BCCs: K14-positive, K6-positive overlying epidermis,
terminal differentiation marker (loricrin)-negative, and a
decrease in basement membrane proteins (BPAG2 and
laminin5) (data not shown). In order to determine the
tumorigenic potential of ShhWrinkled epidermis, embryonic
back skin was grafted onto SCID recipient mice; tumour
growths were visible one month after grafting, and ulceration
was evident in several affected grafts (Fig. 3M,N). Adult
ShhWrinkled graft skin displayed a variety of skin lesions
including epidermal hyperplasia (Fig. 3P), sebaceous
hyperplasia (Fig. 3P), basaloid follicular harmatomas (BFHs)
(Fig. 3T), regions resembling micro nodular BCCs (Fig.
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Fig. 2. Shh and Dhh overexpression
results in epidermal basal cell
anomalies. (A,D) Wild-type skin is
characterised by a single-cell layer
of basal cells. (B,E) Wrinkled
transgenic skin on the other hand
presents with an increase in the
number of basal cell layers, (H,N)
the epidermis exists in a
hyperproliferative state and (K)
exhibits a delay in terminal
differentiation. (C,F) Translucent
skin lacks a substantial amount of
basal cells and (L) presents as a
bilayer of differentiated cells.
(O) Few proliferative cells are
observed within the basal layer of
Translucent skin (arrows), with
proliferation mainly restricted to
basaloid lesion invaginating into
the dermis (unbroken lines).
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3O,R) and sclerosing BCCs (Fig. 3Q,S). In situ hybridisation
analysis of ShhWrinkled skin revealed ectopic suprabasal
expression of Shh, (Fig. 4A) and Ptc1 (Fig. 4B), which is
normally restricted to the basal cells of wild-type skin.
Despite this suprabasal expression, there is a lack of stratified
epithelium phenotype, suggesting that hedgehog pathway
activity has no effect on differentiated keratinocytes. High
levels of Gli1 (Fig. 4C) and Gli2 mRNA were present in
tumour cells, but not in the overlying epidermis. No change
in Gli3 expression was observed. Interestingly there is a
complete ablation of Ptc1 expression within the basal cells of
ShhWrinkled epidermis (Fig. 4B, arrow), suggesting that Shh
promotes basal cell hyperplasia by inhibiting Ptc attenuation
and negative feedback inhibition of the Shh signal.
Shh overexpression can deplete the epidermis of
proliferating basal cells while maintaining
tumorigenic potential
ShhTranslucent embryos showed very little epidermal thickening
or keratinisation and displayed a complete lack of hair follicle
or sebaceous structures (Fig. 3F). Instead, the skin consisted of
an epidermal bilayer with a thin and dispersed dermis. The
epidermal bilayer of ShhTranslucent embryos did not express
keratin 18 (a periderm marker, data not shown), and expressed
the terminal differentiation markers K10 (data not shown) and
loricrin (Fig. 2L), indicating that the process of terminal
differentiation remained unaffected. In contrast to the basal cell
hyperplasia present in ShhWrinkled embryos, we observed a
substantial (approximately 70%) loss of basal cells, with only
Fig. 3. Histological analysis of
hedgehog-induced skin lesions.
(A) Wild-type skin is opaque in
colour and (D) presents with
regularly spaced skin folds and
hair follicles. Wrinkled
transgenic skin on the other hand
presents with excessive skin
folds (B) and is characterised by
epidermal hyperplasia (E).
(C) Translucent transgenic skin
is macroscopically thin and
fragile (arrowheads) with regions
of opaque blisters (arrows) and
(F) presents as an epidermal
bilayer that lacks any HF or
sebaceous structures.
(G-K) Basal cell lesions were
evident from E17.5 in both
Wrinkled (G-I) and Translucent
epidermis (J,K). Lesions
displayed clefting (G,I,K,
arrows) and palisading cells,
characteristic of human BCCs.
(L-M) Gross morphology of
wild-type (L) and Wrinkled
(M,N) skin grafts two months
post-graft. (M) Grafts from
Wrinkled embryonic skin
displayed thick tumour masses
and ulceration was often evident
(arrow). (P) Histological analysis
of Wrinkled graft skin identified
epidermal hyperplasia,
sebaceous hyperplasia, and
(O,T,Q-S) basaloid growths such
as basaloid follicular
harmatomas (BFHs) (T) and
regions resembling micronodular
(O,R, arrows) and sclerosing
BCCs (Q,S).
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sporadic clusters of keratin 14 mRNA (Fig. 2C) and protein
(Fig. 2F) detectable along the epidermis in ShhTranslucent
embryos. Upon further examination, all K14-expressing cells
were found to express the differentiation marker K10,
characterising them as committed early differentiating (PMD)
cells. The absence of any immature K14 basal cells shows that
ectopic Shh pathway activity can lead to the depletion of
epidermal progenitor cells. Consistent with the observation that
ShhTranslucent epidermis consists of only committed epidermal
cells, we observed no K6 expression (Fig. 2I) and negligible
interfollicular proliferative activity (Ki67, data not shown, and
PCNA, Fig. 2O). ShhTranslucent embryonic epidermis also
displayed basaloid invaginations (Fig. 3J,K) which were
classified as BCC-like based on their histological analysis, the
expression of Gli1, Gli2 and Ptc1 and the observation that they
displayed the same antibody profile as observed in human
BCCs. Expression of the proliferation markers Ki67 (data not
shown) and PCNA (Fig. 2O, arrows) was mainly restricted to
within these basaloid lesions. The tumorigenic potential of
ShhTranslucent skin could not be analysed, given 0/14 successful
skin grafts (compared to 11/12 for the ShhWrinkled phenotype).
The extent of Shh pathway perturbation was difficult to discern
due to the substantial loss of epidermal basal cells, alongside
poor epidermal stratification and cell morphology, however, we
did observe regions of intense Shh (Fig. 4D), Ptc1 (Fig. 4E)
and Gli1 (Fig. 4F) expression within the interfollicular PMD
cells and basal lesions of ShhTranslucent skin, indicating ectopic
hedgehog pathway activation.
Shh pathway activity regulates the fate of epidermal
progenitor cells
In order to further characterise the proliferative potential of
ShhWrinkled and ShhTranslucent epidermis, we analysed the
expression of the transcription factor p63 which is normally
expressed in a subset of embryonic epidermal basal cells (Fig.
5A), and is thought to maintain the proliferative potential of
basal cells (Koster and Roop, 2004; McKeon, 2004). p63
expression can therefore be used to mark epidermal
progenitor cells. We observed a substantial increase in the
number of basal cells expressing p63 in ShhWrinkled epidermis,
with expanded p63 expression detected in up to four basal
cell layers (Fig. 5C). In order to determine whether Shh
activity augments epidermal proliferative activity by directly
increasing the pool of epidermal progenitor cells, we
analysed the clonogenic growth potential of ShhWrinkled
keratinocytes using a well-characterised in vitro cell culture
assay system (Bickenbach and Chism, 1998; Kaur and Li,
2000). Primary keratinocytes from E18.5 ShhWrinkled
transgenic embryos and wild-type littermate controls were
plated at 106 per 60 mm dish and the epidermal progenitor
population enriched for by rapid attachment (10 minutes) to
collagenI/fibronectin-coated dishes. Cell cultures were
analysed following 4 weeks of cultivation. The results from
three independent experiments revealed that ShhWrinkled
keratinocytes consistently gave rise to greater numbers of
colonies compared to wild-type controls, i.e. 151±19 versus
41±4, respectively, reflecting a three-fold increase in colony
numbers from ShhWrinkled skin. In addition, ShhWrinkled
keratinocyte cultures displayed an increase in colony density
with respect to wild-type controls (represented in Fig. 6C and
Fig. 6B, respectively), thereby supporting our observation
that ShhWrinkled keratinocytes are hyperproliferative. These
data therefore show that Shh can induce epidermal progenitor
cell hyperplasia and that Shh promotes the proliferation of
epidermal stem cells and their immediate progeny. In
contrast, ShhTranslucent embryos exhibited a complete absence
of epidermal p63 expression (Fig. 5D). We therefore
performed in vitro keratinocyte analyses in order to determine
the growth potential of ShhTranslucent epidermis. Consistent
with the observation that ShhTranslucent skin exhibits a severely
depleted basal compartment we obtained a limited (13103)
number of primary keratinocytes, which failed to attach,
survive or grow, under the same conditions used to culture
wild-type and ShhWrinkled keratinocytes. The inability of
ShhTranslucent embryonic back skin to graft onto SCID mice
(0/14) also supports a lack of epidermal regeneration
capacity. We also speculate that epidermal stem cells of the
bulge are absent in ShhTranslucent skin, given the absence of
any hair follicle structures in these mice. Definitive evidence
of the absence of follicular stem cells requires the
identification of appropriate markers for these cells. Although
CD34 has recently been shown to be a marker for the adult
murine hair follicle bulge region (Trempus et al., 2003), and
although we could detect the expression of CD34 in wild-type
adult epidermis, CD34 was not expressed in embryonic
(E18.5) epidermis (data not shown), suggesting that it is not
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Fig. 4. Hedgehog pathway activity is perturbed in embryonic
Wrinkled and Translucent skin phenotypes. (A) Shh
expression is evident in both the basal and suprabasal layers
of E18.5 Wrinkled epidermis. (B) Although Ptc1 expression is
evident in stratified epithelia of Wrinkled skin, endogenous
Ptc1 expression is completely ablated within the basal cell
compartment (arrow). (D,E) High levels of Shh (D) and Ptc1
(E) expression are present within the PMD cells and basaloid
lesions of E18.5 Translucent epidermis. We also observed
high levels of Gli1 within the basaloid lesions of Wrinkled
(D) and Translucent (J) skin.
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a suitable marker for the embryonic follicular stem cell
compartment.
To identify the impact that loss of Shh pathway activity has
on the epidermal proliferative compartment, we analysed the
expression of p63 in the skin of E17.5 and E18.5 Shh null
embryos and consistently observed a modest decrease in the
number of p63-positive epidermal cells (Fig. 5B). Thus
although epidermal homeostasis remains largely unaffected in
the absence of Shh activity, ectopic Shh expression can result
in epidermal progenitor cell hyperplasia or hypoplasia.
The level of ectopic Shh activity directs epithelial
cell response
The observation that hK14-Shh transgenics present with a
range of skin and developmental phenotypes that appeared to
increase in severity from ShhRegular, to ShhWrinkled, to ShhTaut
and finally ShhTranslucent, suggests that each phenotype may
result from increasing levels of hedgehog transgene activity.
RNA in situ analysis showed an increase in transgene
expression from ShhRegular, through ShhWrinkled, to ShhTaut
(Fig. 7A-C), as determined by a transgene-specific RNA
probe. However, transgene analysis was hindered in the
ShhTranslucent phenotype due to the severe depletion of basal
cells in which transgene expression is directed (Fig. 7D).
Genomic PCR analyses were used in order to determine the
relative copy number associated with each skin phenotype.
PCR analyses indicate an increase in transgene copy number
from ShhRegular, to ShhWrinkled, to ShhTaut, thereby supporting
our RNA in situ expression level data. In addition, genomic
copy number analyses indicate that ShhTranslucent embryos
have a consistently higher transgene copy number than other
phenotypes (Fig. 7E).
Dhh, but not Ihh, can regulate epidermal
homeostasis and induce tumour formation
In order to address the question of functional redundancy
of three mammalian hedgehog molecules during skin
morphogenesis and tumour formation, we overexpressed both
Dhh and Ihh using the hK14 promoter. Dhh overexpression in
the basal cells of murine epithelial tissues resulted in 23
independent hK14-Dhh transgenic embryos with phenotypes
that are indistinguishable from Shh overexpression. We
observed 11/23 DhhRegular (cf 10/27 ShhRegular) transgenics that
displayed no epidermal anomalies. A small number of ShhTaut
(2/27) and DhhTaut (4/23) transgenics parallelled the previously
published report of Shh overexpression (Oro et al., 1997). We
also observed 4/23 DhhWrinkled (cf 8/27 ShhWrinkled) transgenic
embryos with excessive wrinkling of the skin, characterised by
the excess proliferation of suppernumerary progenitor cells.
The remaining 4/23 DhhTranslucent (cf 7/27 ShhTranslucent)
transgenics exhibited a translucent skin phenotype,
characterised by an apparent loss of epidermal tissue
maintenance. These data demonstrate that although Dhh is not
normally expressed in the skin, it can act as a functional
homologue of Shh in regulating epidermal regeneration and
stem cell homeostasis. In addition, the observation that
DhhWrinkled, DhhTaut and DhhTranslucent epidermis develop a
variety of skin tumours, including BCC-like lesions, indicate
for the first time that Dhh has tumorigenic potential.
Twenty-eight independent Ihh transgenic embryos were
produced and no overt HF, sebaceous or interfollicular
epidermal phenotypes were observed (hence 28 IhhRegular
transgenic). Although Ihh overexpression did not result in an
epidermal phenotype, it gave rise to a mild embryonic limb
phenotype (refer to Fig. 1B-D). Previously published data
have shown that although both Shh and Dhh have strong
polarising activity in the developing limb bud, Ihh (even at
high concentrations) gives rise to only minor digit
duplications of the chick wing (Pathi et al., 2001). These
results support our observations that Ihh, although capable of
inducing the same phenotype as low levels of Shh activity, is
not homologous with the ability of Shh to induce strong
polarising effects in the limb. In support of Ihh functional
activity we observed high levels of Ihh transgene (Fig. 8A)
and Ihh protein (Fig. 8B) expression within the basal layer of
IhhRegular transgenic epidermis. In addition, we observed high
levels of endogenous Shh (Fig. 8C) and Ptc1 (Fig. 8D)
Fig. 5. Analysis of p63 expression in E18.5 Shh mouse models.
(A) Within wild-type epidermis, p63 is expressed within a subset of
epidermal basal cells. (B) Loss of Shh activity (Shh null embryos)
does not alter the expression of p63 within the basal cell
compartment. (C) Wrinkled epidermis displays a marked increase in
the number of epidermal cells expressing p63 whereas (D)
Translucent skin displays a complete ablation of p63 expression. 
Fig. 6. Shh pathway activity can increase
keratinocyte growth potential. (A) E18.5 wild-
type epidermis contains an average of 41
keratinocyte colonies per mouse whereas
Wrinkled epidermis contains over 150
keratinocyte colonies per mouse. (B,C) A typical
representation of wild-type colony density (B)
and Wrinkled colony density (C). Translucent
keratinocytes lacked colony-forming efficiency.
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expression in the basal layer and high levels of Gli1 and
Gli2 expression in the HFs of IhhRegular skin. Since Ihh
overexpression had no effect on embryonic epidermal
development, we grafted E18.5 back skin from 18 IhhRegular
transgenic embryos onto SCID recipient mice, in order to
determine whether ectopic Ihh activity had any effect on adult
epidermal homeostasis. Grafts were monitored weekly for 6
months and both macroscopic and histological analysis
revealed epidermal morphology indistinguishable from wild-
type graft controls (data not shown). We have therefore shown
that Ihh pathway activity does not induce an epidermal
phenotype and it is therefore not functionally redundant
with Shh. In addition, our data suggest that epidermal
responsiveness to the hedgehog signal lies downstream of Gli
gene transcriptional regulation.
Discussion
A novel role for the Shh pathway in maintaining the
epidermal stem cell population
This report describes the characterisation of two novel
hedgehog-induced skin phenotypes, Translucent and Wrinkled,
in response to the ectopic activation of Shh and Dhh signalling
in the basal cells of the skin, and shows that hedgehog pathway
activity can directly regulate the number of epidermal basal
cells with stem cell characteristics. Our analyses of
Shh/DhhWrinkled epidermis identified a marked increase in the
number of epidermal progenitor cells in addition to elevated
proliferation of epidermal progenitors in culture. The
observation that Shh plays an important role in epidermal stem
cell biology is consistent with recent observations that Shh
signalling is required for the maintenance of adult neural
progenitor cells (Machold et al., 2003), and promotes
neocortex progenitor cell proliferation (Palma and Ruiz i
Altaba, 2004). However unlike the telencephalon in which Shh
has no effect on embryonic stem cell morphogenesis (Machold
et al., 2003), we show that Shh pathway activity can promote
embryonic progenitor cell hyperplasia. We have also shown
that the Shh pathway can function as a negative regulator of
epidermal stem cell fate. Shh/DhhTranslucent transgenic skin was
devoid of epidermal progenitor cell activity and consisted of a
thin bilayer of committed epidermal cells. This is an
unexpected and novel role for Shh signalling in epidermal stem
cell biology. Interestingly, although loss of Shh activity in the
neocortex results in a loss of epidermal stem cell maintenance,
epidermal stem cell homeostasis remains largely unaffected in
Shh null mice. We infer that an epidermal stem cell phenotype
is not observed in the absence of Shh due to the presence
of extensive compensatory mechanisms employed by the
epidermis to maintain the functional attributes of skin. This
interpretation is consistent with the rare incidence of genetic
knockout mouse models that present with substantial loss of
epidermal tissue, p63 knockout mice and our Shh/DhhTranslucent
embryos being the only exceptions (Mills et al., 1999; Yang et
al., 1999). The results presented here show that hedgehog is a
key factor whose expression must be temporally regulated to
ensure epidermal stem cell homeostasis. Although further
evidence is required to elucidate the specific role that Shh and
its downstream targets play within the epidermal stem cell
niche, our data suggest that above a certain threshold of
hedgehog pathway activation, Shh acts as a mitogen, thereby
increasing the proliferative potential of epidermal basal cells.
This hypothesis is consistent with the observation that Shh
appears to induce proliferation at the onset of anagen, when
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Fig. 7. The level of hedgehog expression increases with the severity
of the skin phenotype. (A-C) RNA in situ analysis of transgene
expression showed an increase in transgene expression from Regular
(A), to Wrinkled (B) and to Taut (C). (D) Detection of transgene
expression within Translucent skin was hindered by the decrease in
basal cells. (E) Genomic PCR analyses indicate that the relative level
of transgene copy number is Translucent > Wrinkled > Regular. This
suggests that differences between transgenic phenotypes may be
related to the level of transgene copy number, and an increase in
embryonic phenotype severity correlates with a significant increase
in copy number.
Fig. 8. Ihh overexpression perturbs epidermal hedgehog signalling activity. In response to high levels of Ihh transgene expression (A) and
ectopic Ihh protein within the basal cells of mouse skin (B), we observed high levels of Shh (C) and Ptc1 (D) expression in both the basal and
suprabasal layers of E18.5 Ihh transgenic epidermis.
5017Epidermal proliferative compartment modulation
the stem cells of the bulge are required to proliferate and give
rise to a new hair shaft (Oro and Higgins, 2003).
Given the perinatal lethality associated with our embryonic
phenotypes, the production of viable conditional Shh
overexpression mouse model systems is required in order to
analyse the progression/regression of the stem/progenitor
cell population over time. An inducible conditional Shh
overexpression system would also allow the documentation of
precise timing of transgene expression onset, thus elucidating
the role of heterochronic transgene expression in producing a
given skin phenotype. We are currently in the process of
transgenic animal production, which will allow us to further
analyse the role of Shh and Dhh target genes in regulating
epidermal basal cell homeostasis. However, the data presented
here show a consistent trend between the level of Shh activity
and the resulting skin phenotype, suggesting that the difference
between the observed phenotypes is probably related to the
level of transgene expression, with the Translucent phenotype
resulting from the highest level of Shh expression. Such a
mechanism would be consistent with the known dose
dependency of Shh action in tissues such as the developing
central nervous system. This is also consistent with the
observation that different levels of hedgehog signalling activity
give rise to different skin phenotypes and skin lesions
(Grachtchouk et al., 2003). The loss of epidermal progenitor
cells in ShhTranslucent epidermis may be due to the exhaustion
of the stem cell compartment; however, given that almost no
basal cells remain, it is possible that high levels of ectopic Shh
activity act to inhibit epidermal stem cell fate.
Hedgehog-induced proliferation is restricted to the
epidermal basal cell compartment: the cellular
origin of hedgehog-induced skin tumours
Previous overexpression studies have shown that elevated
hedgehog pathway activity in the basal cells of the skin, using
basal specific promoters (K5 and K14), gives rise to epidermal
anomalies and BCC-like lesion formation (Grachtchouk et al.,
2003; Oro et al., 1997; Sheng et al., 2002; Xie et al., 1998).
However, we have recently shown that overexpression of
hedgehog in only a subset of basal cells, using the human K1
promoter (hK1), results in the ablation of embryonic hair
follicle development and does not give rise to BCC (Ellis et al.,
2003). The overexpression of hedgehog via the hK1 promoter
drives hedgehog activity in committed epidermal cells, thus
only in a small subset (20-30%) of basal cells, the PMD-
population. In contrast, the overexpression of hedgehog via the
hK14 promoter drives Shh activity in all basal cell populations.
The hedgehog-induced skin phenotype differences observed in
hK14-Shh and hK1-Hh transgenic mice could be attributed to
the timing at which hedgehog activity is induced by the keratin
promoters (hK14: E9.5 versus hK1: E12.5). However, in view
of the data presented here, it is a possibility that the major
contributing factor is the activity of the hedgehog pathway in
the epidermal progenitor compartment.
Although BCCs are the most common form of human skin
cancer, much remains to be elucidated about the aetiology,
including the cellular origin. The outer root sheath (ORS) cells
of the hair follicles are strong candidates given that BCCs are
seldom observed in hairless regions of the body and appear to
invaginate from structures resembling HFs (Weedon, 1981).
BCC also has an immature, stem cell-like appearance leading
to the suggestion that BCC originates from aberrant Shh
activity within the stem cell population of the interfollicular
epidermis or those of the hair follicle bulge (Taipale and
Beachy, 2001; Zhang and Kalderon, 2001). We observed hK14-
Shh and hK14-Dhh embryonic skin either enriched or devoid
of epidermal progenitor cell activity and/or hair follicles is
equally competent to produce BCC. We hypothesise that
hedgehog induces BCC transformation via promoting the
proliferation and subsequent invagination of cells residing in
the basal compartment. This is consistent with the proliferative
effect of Shh on epidermal cells (Fan and Khavari, 1999; Fan
et al., 1997; Morgan et al., 1998; Oro et al., 1997; Sato et al.,
1999), and the role it plays during invagination of the
developing hair follicle (Chiang et al., 1999; St-Jacques et al.,
1998). Although we can not rule out the possibility that stem
cells sustain genetic mutations that predispose their progeny to
transformation, the results presented here suggest that neither
stem cells nor ORS cells of the hair follicle are required for
BCC formation. Although both stem cells and ORS cells reside
in the basal compartment, and, according to our hypothesis can
act as the cellular origin to hedgehog pathway-induced skin
tumours, our data show that BCC transformation can occur in
basal cells lacking inherent self-renewing potential. Consistent
with this suggestion, only 26% of human BCCs exhibit p63
expression (Dellavalle et al., 2002), thus representing the
subset of BCCs that arose within the epidermal progenitor
compartment.
Dhh, but not Ihh, is a functional homologue of Shh
signalling in the skin
In vitro biochemical evidence has shown that Shh, Dhh and Ihh
have equal binding affinities for the Ptc1 receptor thereby
suggesting that redundancy between hedgehog protein activity
may exist (Carpenter et al., 1998). In vitro data have since
identified a degree of functional homology amongst Shh
and Ihh proteins in hypertrophic chondrocyte differentiation
(Vortkamp et al., 1996) and osteoblastic differentiation (Kinto
et al., 1997), and among Shh, Dhh and Ihh proteins during
motor neuron induction and polarisation of the developing limb
(Pathi et al., 2001). In order to further characterise the role
of Shh signalling in maintaining the epidermal stem cell
population and promoting basal cell proliferation, we
overexpressed the mammalian homologues Dhh and Ihh in the
basal cells of mouse skin and observed that Dhh, but not Ihh,
is a functional homologue of Shh activity during epidermal
stem cell homeostasis and skin tumour formation. Recent work
by Watt and colleagues (Niemann et al., 2003) led to the
hypothesis that Ihh plays a role in the proliferation of
sebaceous cells, given the expression of Ihh in sebaceous
tumours of K14- D N-Lef1 mice. Our K14-Ihh transgenic
epidermis directly tests this hypothesis, and despite ectopic
expression of Ihh protein in the basal cells of IhhRegular
epidermis and activation of Shh and Ptc1 expression, there was
no evidence of hair follicle or sebaceous lineage defects, nor
any overt proliferative activity. These data suggest that the
expression of Ihh within K14- D N-Lef1 mice is not causative
of sebaceous hyperplasia, but rather a consequence of
inappropriate b -catenin signalling.
Our observation that Dhh overexpression gives rise to
embryo phenotypes indistinguishable from Shh overexpression
shows that Dhh is a functional homologue of Shh in epithelial
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cells, and in particular, that ectopic Dhh pathway activation
plays a role in regulating the proliferation of the epidermal
basal cell compartment. Given that cancer can be seen as a
disease of unregulated cell renewal, an understanding of the
mechanisms underlying epidermal proliferative activity is
fundamental to understanding how cancer cells obtain
unlimited proliferative potential. The data presented here show
that both Shh and Dhh signalling activity can result in
epidermal hyperplasia or hypoplasia. Thus the elucidation of
those targets common to both Shh and Dhh signalling may
help identify the genes involved in epidermal cell renewal and
those genes responsible for BCC formation. Our data also
suggest that the current deficiencies in effective epidermal cell
culture for tissue therapies might usefully be addressed
by manipulation of the hedgehog pathway, such that the
magnitude and timing of Shh activity can be used to drive basal
cell proliferation, resulting in increased epidermal proliferation
without disrupting epidermal stratification.
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